Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
Owonikoko, T.K., Kim, H.R., Govindan, R., Ready, N., Reck, M., Peters, S., Dakhil, S.R., Navarro, A., Rodriguez-Cid, J., Schenker, M., Lee, J.S., Gutierrez, V., Percent, I., Morgensztern, D., Fairchild, J., Baudelet, C., Park, K.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
Reck, M., Vicente, D., Ciuleanu, T., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Wolf, J., Antonia, S.J., Nakagawa, K., Selvaggi, G., Baudelet, C., Chang, H., Spigel, D.R.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Thalidomide Radiosensitizes Tumors through Early Changes in the Tumor Microenvironment
ANSIAUX, Réginald, BAUDELET, Christine, JORDAN, Bénédicte F, BEGHEIN, Nelson, SONVEAUX, Pierre, DE WEVER, Julie, MARTINIVE, Philippe, GREGOIRE, Vincent, FERON, Olivier, GALLEZ, Bernard
Published in Clinical cancer research (15.01.2005)
Published in Clinical cancer research (15.01.2005)
Get full text
Journal Article
Web Resource
Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer
Ramalingam, S.S, Mazières, J, Planchard, D, Stinchcombe, T.E, Dy, G.K, Antonia, S.J, Horn, L, Lena, H, Minenza, E, Mennecier, B, Otterson, G.A, Campos, L.T, Gandara, D.R, Levy, B.P, Nair, S.G, Zalcman, G, Wolf, J, Baudelet, C, Lestini, B.J, Rizvi, N.A
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Published in International journal of radiation oncology, biology, physics (01.12.2014)
Get full text
Journal Article
PW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers
Vieta, E, Owen, R, Baudelet, C, McQuade, R, Sanchez, R, Fyans, P, Loze, J.-Y, Marcus, R
Published in European psychiatry (2010)
Published in European psychiatry (2010)
Get full text
Journal Article
68P Evaluation of flat dosing for nivolumab (NIVO) + ipilimumab (IPI) in first-line (1L) unresectable malignant pleural mesothelioma (MPM): CheckMate 743 (CM 743)
Tsao, A.S., Baas, P., Nowak, A., Zalcman, G., Fujimoto, N., Peters, S., Baudelet, C., Aanur, P., Osawa, M., Tendolkar, A., Y.Feng, Sheng, J.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
749P Nivolumab (N) alone or in combination with ipilimumab (I) in patients (pts) with platinum-pretreated metastatic urothelial carcinoma (mUC): Extended follow-up from CheckMate 032
Sharma, P., Siefker-Radtke, A.O., de Braud, F., Basso, U., Calvo, E., Bono, P., Morse, M., Ascierto, P.A., Lopez-Martin, J., Brossart, P., Rohrberg, K.S., Mellado, B., Li, S., Baudelet, C., Unsal-Kacmaz, K., Callahan, M.K., Rosenberg, J.E.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
Baas, P., Scherpereel, A., Nowak, A., Fujimoto, N., Peters, S., Tsao, A., Mansfield, A., Popat, S., Jahan, T., Antonia, S., Oulkhouir, Y., Bautista, Y., Cornelissen, R., Greillier, L., Grossi, F., Kowalski, D.M., Rodriguez-Cid, J., Aanur, P., Baudelet, C., Zalcman, G.
Published in Journal of thoracic oncology (01.10.2020)
Published in Journal of thoracic oncology (01.10.2020)
Get full text
Journal Article
A randomized, open-label, phase 3 study of nivolumab in combination with ipilimumab vs extreme regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as first-line therapy in patients with recurrent or metastatic squamous cell carcinoma of the head and neck-CheckMate 651
Argiris, A., Gillison, M., Ferris, R.L., Harrington, K., Sanchez, T.K., Baudelet, C., Geese, W.J., Shaw, J., Haddad, R.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
LBA1_PRNivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
Owonikoko, T K, Kim, H R, Govindan, R, Ready, N, Reck, M, Peters, S, Dakhil, S R, Navarro, A, Rodriguez-Cid, J, Schenker, M, Lee, J S, Gutierrez, V, Percent, I, Morgensztern, D, Fairchild, J, Baudelet, C, Park, K
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Double-blind, two-arm, phase 2 study of nivolumab (nivo) in combination with ipilimumab (ipi) versus nivo and ipi-placebo (PBO) as first-line (1L) therapy in patients (pts) with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN)—CheckMate 714
Haddad, R., Gillison, M., Ferris, R.L., Harrington, K., Monga, M., Baudelet, C., Geese, W.J., Argiris, A.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications
Gallez, Bernard, Baudelet, Christine, Jordan, Bénédicte F.
Published in NMR in biomedicine (01.08.2004)
Published in NMR in biomedicine (01.08.2004)
Get full text
Journal Article
LBA5Efficacy and safety of nivolumab (nivo) monotherapy versus chemotherapy (chemo) in recurrent small cell lung cancer (SCLC): Results from CheckMate 331
Reck, M, Vicente, D, Ciuleanu, T, Gettinger, S, Peters, S, Horn, L, Audigier-Valette, C, Pardo, N, Juan-Vidal, O, Cheng, Y, Zhang, H, Shi, M, Wolf, J, Antonia, S J, Nakagawa, K, Selvaggi, G, Baudelet, C, Chang, H, Spigel, D R
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article
Evidence for a neuroprotective effect of pyrid-3-yl-sulphonyl-urea in photochemically induced focal ischaemia in rats: magnetic resonance imaging evaluation
Baudelet, C, Demeure, R, Frois, A, Masereel, B, Goudemant, J F, Ritter, C, Gallez, B
Published in Journal of pharmacy and pharmacology (01.08.1999)
Published in Journal of pharmacy and pharmacology (01.08.1999)
Get more information
Journal Article